{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:45:46Z","timestamp":1791805546125,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["769036"],"award-info":[{"award-number":["769036"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmg.2021.104370","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T02:58:19Z","timestamp":1635735499000},"page":"104370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care"],"prefix":"10.1016","volume":"65","author":[{"given":"C.L.","family":"Shovlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Buscarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sabb\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Mager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pagella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Sure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Torring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Suppressa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Lenato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lefroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Kariholu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Fialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.F.","family":"Eker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Droege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Coote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Boccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alsafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alicante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dupuis-Girod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejmg.2021.104370_bib1","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib3","first-page":"3","article-title":"Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence","volume":"44","author":"Bideau","year":"1989","journal-title":"Population"},{"issue":"4","key":"10.1016\/j.ejmg.2021.104370_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/cid\/cix373","article-title":"Cerebral abscess associated with odontogenic bacteremias, hypoxemia, and iron loading in immunocompetent patients with right-to-left shunting through pulmonary arteriovenous malformations","volume":"65","author":"Boother","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. l_2","key":"10.1016\/j.ejmg.2021.104370_bib5","first-page":"A156","article-title":"International similarities and differences in hereditary hemorrhagic telangiectasia (HHT) pathways reported by patients and clinicians","volume":"74","author":"Boother","year":"2019","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13023-018-0982-4","article-title":"Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Buscarini","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejmg.2021.104370_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00701-017-3154-8","article-title":"European consensus conference on unruptured brain AVMs treatment","volume":"159","author":"Cenzato","year":"2017","journal-title":"Acta Neurochir."},{"issue":"12","key":"10.1016\/j.ejmg.2021.104370_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jmedgenet-2019-106794","article-title":"Low grade mosaicism in hereditary haemorrhagic telangiectasia identified by bidirectional whole genome sequencing reads through the 100,000 Genomes Project clinical diagnostic pipeline","volume":"57","author":"Clarke","year":"2020","journal-title":"J. Med. Genet."},{"issue":"9","key":"10.1016\/j.ejmg.2021.104370_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMc1213554","article-title":"Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia","volume":"368","author":"Devlin","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13023-019-1286-z","article-title":"Hereditary haemorrhagic telangiectasia and pregnancy: a review of the literature","volume":"15","author":"Dupuis","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104370_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000479632","article-title":"The lung in hereditary hemorrhagic telangiectasia","volume":"94","author":"Dupuis-Girod","year":"2017","journal-title":"Respiration"},{"key":"10.1016\/j.ejmg.2021.104370_bib12","author":"Dupuis-Girod"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13023-020-01386-9","article-title":"European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)","volume":"15","author":"Eker","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104370_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","author":"European Association for the Study of the Liver","year":"2016","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.ejmg.2021.104370_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.ejmg.2021.104370_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076516","article-title":"Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency","volume":"8","author":"Finnamore","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmg.2021.104370_bib53","series-title":"Clinical Practice Guidelines We CanTrust. Institute of Medicine (US) Committee on Standards for DevelopingTrustworthy Clinical Practice Guidelines","year":"2011"},{"key":"10.1016\/j.ejmg.2021.104370_bib19","author":"Kjeldsen"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","article-title":"Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients","volume":"245","author":"Kjeldsen","year":"1999","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejmg.2021.104370_bib2","unstructured":"HHT Mutation Database, 2021. Hosted by the ARUP Laboratories, University of Utah. http:\/\/www.arup.utah.edu\/database\/HHT."},{"key":"10.1016\/j.ejmg.2021.104370_bib21","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/jac\/dkw081","article-title":"Intravenous amoxicillin\/clavulanate for the prevention of bacteraemia following dental procedures: a randomized clinical trial","volume":"71","author":"Limeres Posse","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"10.1016\/j.ejmg.2021.104370_bib22","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/ajmg.a.38695","article-title":"Tissue-specific mosaicism in hereditary hemorrhagic telangiectasia: implications for genetic testing in families","volume":"176","author":"McDonald","year":"2018","journal-title":"Am. J. Med. Genet."},{"issue":"9917","key":"10.1016\/j.ejmg.2021.104370_bib23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)62302-8","article-title":"Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (Aruba): a multicentre, non-blinded, randomised trial","volume":"383","author":"Mohr","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejmg.2021.104370_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/01.wnl.0000194257.75559.b0","article-title":"Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine","volume":"66","author":"Post","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ejmg.2021.104370_bib25","series-title":"Rare Disease Patients' Experience of COVID-19: Hereditary Hemorrhagic Telangiectasia","author":"Rare Barometer Voices","year":"2020"},{"issue":"10","key":"10.1016\/j.ejmg.2021.104370_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184227","article-title":"Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: haemodynamic profiles and survival probability","volume":"12","author":"Revuz","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejmg.2021.104370_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104370_bib28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1513\/AnnalsATS.201611-872OC","article-title":"Hemoglobin is a vital determinant of arterial oxygen content in hypoxemic patients with pulmonary arteriovenous malformations (figure, 4)","volume":"14","author":"Rizvi","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.ejmg.2021.104370_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.ejmg.2021.104370_bib29","author":"Shovlin"},{"key":"10.1016\/j.ejmg.2021.104370_bib30","author":"Shovlin"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"9","key":"10.1016\/j.ejmg.2021.104370_bib32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1471-0528.2008.01786.x","article-title":"Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for obstetric services","volume":"115","author":"Shovlin","year":"2008","journal-title":"BJOG"},{"issue":"12","key":"10.1016\/j.ejmg.2021.104370_bib33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/thoraxjnl-2017-210764","article-title":"British Thoracic Society Clinical Statement on pulmonary arteriovenous malformations","volume":"72","author":"Shovlin","year":"2017","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-018-0850-2","article-title":"European Reference Network for Rare Vascular Diseases (VASCERN) Outcome Measures for hereditary haemorrhagic telangiectasia (HHT)","volume":"13","author":"Shovlin","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104370_bib36","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3324\/haematol.2018.209791","article-title":"Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination","volume":"104","author":"Shovlin","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13023-019-1179-1","article-title":"Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Shovlin","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"17","key":"10.1016\/j.ejmg.2021.104370_bib37","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1182\/blood.2019004560","article-title":"Mutational and phenotypic characterisation of hereditary hemorrhagic telangiectasia","volume":"136","author":"Shovlin","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejmg.2021.104370_bib38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.clinre.2020.03.008","article-title":"Hereditary hemorrhagic telangiectasia and liver involvement: vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver","volume":"44","author":"Silvain","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"10.1016\/j.ejmg.2021.104370_bib39","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","article-title":"Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in Bi-allelic loss of ENG or ACVRL1","volume":"105","author":"Snellings","year":"2019","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2021.104370_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mgg3.361","article-title":"ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia","volume":"6","author":"T\u00f8rring","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.ejmg.2021.104370_bib41","series-title":"The European reference network on rare multisystemic vascular diseases (VASCERN)","author":"VASCERN","year":"2017"},{"key":"10.1016\/j.ejmg.2021.104370_bib42","unstructured":"VASCERN, 2018. VASCERN Days 2018. https:\/\/vascern.eu\/vascern-days-2018-highlights-from-our-2nd-annual-seminar\/VASCERN.2018."},{"key":"10.1016\/j.ejmg.2021.104370_bib43","unstructured":"VASCERN, 2019. Orphanet text on HHT updated by the VASCERN HHT-WG. https:\/\/vascern.eu\/orphanet-text-on-hht-updated-by-the-vascern-hht-wg\/2019."},{"key":"10.1016\/j.ejmg.2021.104370_bib44","unstructured":"VASCERN, 2020. VASCERN days 2020. https:\/\/vascern.eu\/vascern-days-2020-accomplishment-of-our-first-online-annual-seminar\/."},{"key":"10.1016\/j.ejmg.2021.104370_bib45","unstructured":"VASCERN HHT, 2019a. Orphanet definition of hereditary haemorrhagic telangiectasia. Available at: www.orpha.net\/consor\/www\/cgi-bin\/OC_Exp.php?lng=EN&Expert=774,2019."},{"key":"10.1016\/j.ejmg.2021.104370_bib46","unstructured":"VASCERN HHT, 2019b. HHT from VASCERN HHT. Mar 2019. https:\/\/www.youtube.com\/watch?v=0YjWf7Agn40."},{"key":"10.1016\/j.ejmg.2021.104370_bib47","unstructured":"VASCERN HHT, 2020. VASCERN HHT Statement on COVID-19. https:\/\/vascern.eu\/wp-content\/uploads\/2020\/03\/VASCERN-HHT-COVID-19-STATEMENT-1.pdf."},{"key":"10.1016\/j.ejmg.2021.104370_bib48","unstructured":"VASCERN HHT, 2021. VASCERN HHT Statement Statement concerning SARS-CoV-2 vaccination for patients with HHT. https:\/\/vascern.eu\/wp-content\/uploads\/2021\/01\/HHT-COVID-vaccination-statement.pdf."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104370_bib49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bjid.2020.07.010","article-title":"Gary Davies on behalf of the ChelWest COVID19 Consortium. Increase in COVID-19 inpatient survival following detection of Thromboembolic and Cytokine storm risk from the point of admission to hospital by a near real time Traffic-light System (TraCe-Tic)","volume":"24","author":"Vizcaychipi","year":"2020","journal-title":"Braz. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104370_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000458447","article-title":"Pulmonary hypertension in a large cohort with hereditary hemorrhagic telangiectasia","volume":"94","author":"Vorselaars","year":"2017","journal-title":"Respiration"},{"issue":"4","key":"10.1016\/j.ejmg.2021.104370_bib51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann. Intern. Med."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221002366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221002366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:51:25Z","timestamp":1761709885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721221002366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1769721221002366"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104370","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104370"}}